跳至主要内容
临床试验/CTRI/2026/01/100148
CTRI/2026/01/100148招募中2 期

Effect of Ozone Therapy as an adjuvant to Conventional Medicine on HbA1C, FBS, PPBS, and QOL in Type 2 Diabetes Mellitus

Dr. Arkaprava Das Adhikary1 个研究点 分布在 1 个国家目标入组 102 人开始时间: 2026年1月12日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
102
试验地点
1

研究概览

简要总结

A study to find the impact of ozone therapy as an adjunct treatment on glycated hemoglobin among patients with type 2 diabetes mellitus and to test the hypothesis of how ozone therapy helps in the management of Type 2 diabetes mellitus.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
21.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Patient is willing to participate History of type 2 diabetes mellitus for the past 1 year Depending on oral or parenteral hypoglycemic medications Zubrods performance status is 0–2.

排除标准

  • Acute alcohol intoxication A recent myocardial infarction Haemorrhage from any organ Pregnancy Hyperthyroidis Thrombocytopenia Severe anaemia Ozone allergy Serious Cardio-Vascular instability Patients on Angiotensin-converting enzyme(ACE) inhibitors G6PD deficiency.

研究者

发起方
Dr. Arkaprava Das Adhikary
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Arkaprava Das Adhikary

Maharishi Aurobindo Subharti College and Hospital of Naturopathy and Yogic Sciences

研究点 (1)

Loading locations...

相似试验